Restricted accessResearch articleFirst published online 2007-09
Intracardiac Thrombosis and Acute Right Ventricular Failure Following Complex Reoperative Cardiac Surgery With Aprotinin and Deep Hypothermic Circulatory Arrest
Although coagulopathy and bleeding are common in the setting of cardiac surgery, a growing number of case reports in the literature suggest that hypercoagulability may also result in significant morbidity and mortality. We present a case of apparent hypercoagulability with formation of thrombus in the cardiac chambers following reoperative cardiac surgery using cardiopulmonary bypass, aprotinin, and deep hypothermic arrest. A review of those hypercoagulable disorders with reported impact on cardiac surgery and a discussion follow the case presentation.
Fanashawe MP , Shore-Lesserson L., Reich DLTwo cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest. Anesthesiology . 2001; 95:1525-1527.
2.
Augostides JG , Lin J., Gambone AJ, et al. Fatal thrombosis in an adult after thoracoabdominal aneurysm repair with aprotinin and deep hypothermic circulatory arrest. Anesthesiology. 2005;103:215-216.
3.
Shore-Lesserson L., Reich DLA case of severe diffuse venous thromboembolism associated with aprotinin and hypothermic circulatory arrest in a cardiac surgical patient with factor V Leiden. Anesthesiology. 2006;105:219-221.
4.
Augostides JG , Kilbaugh T., Harris H., et al. Fatal thrombosis after mitral valve replacement for endocarditis: aprotinin and disseminated intravascular coagulation . Anesthesiology. 2006;104:213.
5.
Cooper JR Jr, Abrams J., Frazier OH, et al. Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy. J Thorac Cardiovasc Surg.2006;131:963-968.
6.
Donahue BSThrombosis after deep hypothermic circulatory arrest with antifibrinolytic therapy: is factor V Leiden the smoking gun? Anesthesiology.2002;97:760-761.
7.
Casati V., Zanetti PP, D'Angelo A.Thrombosis after hypothermic circulatory arrest for cardiovascular surgery, antifibrinolytic drugs and thrombophilia. Anesthesiology.2007;106:874.
8.
Crowther MA, Kelton JGCongenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med.2003;138:128-134.
9.
Morozowich ST , Donahue BS, Welsby IJGenetic of coagulation: considerations for cardiac surgery. Semin Cardiothorac Vasc Anesth.2006;10:297-313.
10.
Heijboer H. , Brandjes DP, Buller HR, et al. Deficiencies of coagulation inhibiting and fibrinolytic proteins in outpatients with deep venous thrombosis. N Engl J Med.1990;323:1512-1516.
11.
Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population . Thromb Haemost.1995;73:87-93.
12.
Miletich J. , Sherman L., Broze G. Jr.Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med.1987;317:991-996.
13.
Koster T., Rosendaal FR, Briet E., et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood.1995;85:2756-2761.
14.
Bonill EG, Bauer KA, Dickerman JD, et al. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood. 1989;73:712-717.
15.
Camerlingo M., Finazzi G., Casto L., et al. Inherited protein C deficiency and non-hemorrhagic arterial stroke in young adults. Neurology . 1992;41:1371-1373.
16.
Sie P., Bonen B., Bierme R., et al. Arterial thrombosis and protein S deficiency. Thromb Haemost.1989;62:1040.
17.
Oysel N., Bonnet J., Vergnes C., et al. Risk factors for myocardial infarction during coronary artery bypass graft surgery. Eur Heart J.1989;10:806-815.
18.
So GM, Herbert MR, Dooling EC, et al. Multifocal embolic strokes following cardiac surgery in a protein C-deficient child. J Child Neurol.1998;13:629-631.
19.
Sievert A., McCall M., Blackwell M., et al.Use of aprotinin during cardiopulmonary bypass in a patient with protein C deficiency. J Extra Corpor Technol.2003;35:39-43.
20.
Spanier TB, Chen JM, Mancini DM, et al. Cardiac transplantation in a patient with protein S deficiency . Ann Thorac Surg.1999;68:1078-1080.
Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population . Br J Haematol.1994;87:106-112.
23.
Wells PS, Blajchman MA, Henderson P., et al. Prevalence of antithrombin deficiency in healthy blood donors: a cross sectional study. Am J Haematol.1994 ;45:321-324.
24.
Moor E., Silveira A., van't Hooft F., et al. Coagulation factor V (Arg506→Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. Thromb Haemost.1998;80:220-224.
25.
Sweeney JD, Blair AJ, Dupuis MP, et al. Aprotinin, cardiac surgery, and factor V Leiden. Transfusion.1997;37: 1173-1178.
26.
Seligsohn U. , Lubetsky A.Genetic susceptibility to venous thrombosis . N Engl J Med.2001;344:1222-1231.
27.
Poort SR, Rosendaal FR, Reitsma PHA common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88: 3698-3703.
28.
Özbek N., Ataç FB, Yildirim SV, et al. Analysis of pro-thrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery. Cardiol Young.2005;15:19-25.
29.
Cattaneo P. , Mariscalco G., Blanzola C., et al. Left ventricular thrombus in a patient with antiphospholipid antibody syndrome and hyperhomocystinemia. Ital Heart J Suppl. 2003;4:54-57.
30.
Rees MM, Rogers GMHomocystinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res.1993;71:337-359.
31.
Doig RG, O'Malley CJ, Dauer R., et al. An evaluation of 200 consecutive patients with spontaneous or recurrent thrombosis for primary hypercoagulable states. Am J Clin Pathol.1994;102:797-801.
32.
Ginsberg JS , Wells PS, Brill-Edwards P., et al. Antiphospholipid antibodies and venous thromboembolism. Blood.1995;86:3685-3691.
33.
Petri M.Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun.2000;15:145-151.
